About Zylo
Zylo Therapeutics, located at Ben Hamby Drive in Greenville, South Carolina, operates an advanced pharmaceutical development facility focused on drug delivery innovation. The lab specializes in:
- Z-pod silica particle technology for enhanced bioavailability
- Targeted delivery systems for medical applications
- Clinical solutions for skin conditions and other disorders
- ISO-9001 and cGMP standard manufacturing
From their Greenville research center, Zylo Therapeutics develops breakthrough encapsulation technologies that have shown up to 20-fold improvement in drug solubility rates.
Frequently asked questions
Zylo Therapeutics develops drug delivery systems through the following technologies:
- Z-pod Technology
- Amorphous silica particles
- Compound encapsulation
- Bioavailability enhancement
- Delivery Applications
- Topical delivery systems
- Sustained release mechanisms
- Targeted drug delivery
- Clinical Development
- Lupus treatment formulations
- Erectile dysfunction applications
- Nail fungus solutions
The technology platform achieves a 20-fold increase in drug solubility for certain compounds.
Zylo Therapeutics’ development framework includes:
| Technology Area | Capabilities |
|---|---|
| Drug Delivery Systems |
|
| Research Applications |
|
| Development Focus |
|
Zylo Therapeutics operates under the following standards and systems:
- Quality Management
- cGMP standards implementation
- ISO-9001 certification process
- Industry authority inspections
- Laboratory Infrastructure
- Research facilities
- Development laboratories
- Testing centers
- Regulatory Compliance
- FDA guidelines adherence
- Safety protocols
- Documentation systems
More details about Zylo
Innovative pharmaceutical development at Zylo Therapeutics
Located in Greenville, South Carolina, Zylo Therapeutics operates as a cosmetic lab and pharmaceutical research facility, advancing the field of drug delivery through innovative technology.
Revolutionary Z-pod technology
At the core of Zylo Therapeutics’ work are Z-pods – specialized silica particles designed to enhance compound delivery and stability. This technology represents a significant advancement in pharmaceutical formulation, improving how active ingredients are delivered to their intended targets.
Enhanced delivery systems
The lab’s proprietary technology has achieved remarkable results in improving compound solubility, with documented increases of up to 20 times the original bioavailability of certain substances.
Research and development capabilities
Operating from their facility on Ben Hamby Drive, the team focuses on:
- Compound encapsulation techniques
- Bioavailability enhancement
- Targeted delivery systems
- Sustained release formulations
Quality assurance and compliance
The South Carolina-based facility maintains high industry standards by:
- Following cGMP guidelines
- Pursuing ISO-9001 certification
- Undergoing regular authority inspections
Clinical applications and solutions
The lab’s technology has shown promising results in various therapeutic areas, including dermatological conditions and topical treatments. Their work in developing targeted delivery systems has applications across multiple medical conditions, positioning them as a leader in pharmaceutical development in the southeastern United States.
Company gallery
